Research on vaccines and antimicrobials during pregnancy: Challenges and opportunities

Vaccine

Volumn 31, Issue 40, 2013, Pages 4261-4263

  Beigi, Richard H ^a   Goldkind, Sara F ^b   Jevaji, Indira ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; INACTIVATED VACCINE; THALIDOMIDE; VACCINE;

2009 H1N1 INFLUENZA; CLINICAL RESEARCH; DEVELOPMENTAL TOXICITY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; INSTITUTIONAL REVIEW; MEDICAL SOCIETY; PANDEMIC; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTIVE TOXICITY; VULNERABLE POPULATION;

ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINES;

EID: 84882970016     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.060     Document Type: Editorial

References (13)

1. Parisi M.A., Spong C.Y., Zajicek A., Guttmacher A.E. We don't know what we don't study: the case for research on medication effects in pregnancy. Am J Med Genet C Semin Med Genet 2011, 157:247-250.
2. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey J., et al. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008, 57:1-60.
3. Jamieson D.J., Honein M.A., Rasmussen S.A., Williams J.L., Swerdlow D.L., Biggerstaff M.S., et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374:451-458.
4. Goldkind S.F., Sahin L., Gallauresi B. Enrolling pregnant women in research - lessons from the H1N1 influenza pandemic. N Engl J Med 2010, 362:2241-2333.
5. Brent R.L. Immunization in pregnant women: reproductive, medical and societal risks. Vaccine 2003, 21:3413-3421.
6. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564.
7. ClinicalTrials.gov. Maternal vaccine studies. [accessed 07.12.12]. http://www.clinicaltrials.gov/ct2/results%3Fterm=maternal+vaccine.
8. Food and Drug Administration General Considerations for the Clinical Evaluation of Drugs. [accessed 07.12.12]. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071682.pdf.
9. Food and Drug Administration, Department of Health and Human Services Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs: notice. Federal Register 1993, 58:39406-39416.
10. CFR - Code of Federal Regulations Title 21. [accessed 07.12.12]. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm.
11. 45 CFR (Public Welfare) part 46 (Protection of Human Subjects) 2005, DHHS, [accessed 07.12.12]. http://www.access.gpo.gov/nara/cfr/waisidx_10/45cfr46_10.html.
12. The International Ethical Guidelines for Biomedical Research Involving Human Subjects. The Council for International Organizations of Medical Sciences in Collaboration with the World Health Organization 2012, CIOMS, Geneva, http://www.cioms.ch/publications/guidelines/guidelines_nov_2002_blurb.htm [accessed 07.12.12].
13. Pregnancy and Lactation Labeling. Available at: [accessed 29.04.13]. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm.